- Q1 2024 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 13, 2024$7.35 (-1.61%)Earnings
- Q4 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptFeb 27, 2024$10.18 (+4.62%)Earnings
- Q3 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 07, 2023$4.29 (+19.50%)Earnings
- Q2 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 03, 2023$3.85 (+0.79%)Earnings
- Q1 2023 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 15, 2023$3.64 (+11.31%)Earnings
- Q4 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 09, 2023$4.82 (-23.00%)Earnings
- Fulcrum Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Fulcrum Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 08, 2022$6.45 (+14.97%)Earnings
- Fulcrum Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 11, 2022$7.57 (-2.45%)Earnings
- Fulcrum Therapeutics Inc To Review Initial FTX-6058 Data And Provide Program Update Call TranscriptJun 10, 2022
- Fulcrum Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 09, 2022$7.66 (-11.24%)Earnings
- Fulcrum Therapeutics Inc To Discuss Unmet Need In FSHD, REACH Trial And Key Measures Of Disease Progression Call TranscriptMar 24, 2022
- Q4 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 03, 2022$11.7 (+5.41%)Earnings
- Fulcrum Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call TranscriptDec 06, 2021
- Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Q3 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 04, 2021$21.15 (+3.27%)Earnings
- Fulcrum Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 10, 2021$18.77 (+125.33%)Earnings
- Fulcrum Therapeutics Inc Annual FSHD Society International Research Congress- Corporate Call TranscriptJun 24, 2021
- Fulcrum Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 06, 2021$10.58 (+5.06%)Earnings
- Q4 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 04, 2021$12.5 (-14.32%)Earnings
- Fulcrum Therapeutics, Inc. - Special Call TranscriptDec 15, 2020
- Q3 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 10, 2020$10.94 (+1.11%)Earnings
- Q2 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptAug 11, 2020$8.9 (-48.01%)Earnings
- Fulcrum Therapeutics, Inc. - Special Call TranscriptJun 10, 2020
- Fulcrum Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Fulcrum Therapeutics Inc Earnings Call TranscriptMay 13, 2020$16.48 (+10.53%)Earnings
- Q4 2019 Fulcrum Therapeutics Inc Earnings Call TranscriptMar 05, 2020$18.5 (+2.78%)Earnings
- Q3 2019 Fulcrum Therapeutics Inc Earnings Call TranscriptNov 14, 2019$7.64 (-3.29%)Earnings
Q3 2019 Fulcrum Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Fulcrum Therapeutics Third Quarter 2019 Conference Call. (Operator Instructions) I would now like to turn the call over to Peter Thomas -- Peter Thomson, Vice President of Finance and Accounting at Fulcrum, please proceed.
Good morning. Welcome to Fulcrum's Third Quarter 2019 Conference Call. We issued a press release earlier today reviewing our third quarter 2019 results and business updates, which will be covered on this call. A replay of today's call will be available on the Investors and Media section of our website. After our prepared remarks, we will open the call for Q&A.
Before we begin, I'd like to mention that our call will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines and financial projections. I encourage you to review our filings with the Securities and Exchange
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)